Sumitomo Mitsui Trust Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.63B | Sell |
1,775,707
-80,425
| -4% | -$81.5M | 1.06% | 12 |
|
|
2025
Q4 | $1.99B | Sell |
1,856,132
-102,900
| -5% | -$98.4M | 1.17% | 11 |
|
|
2025
Q3 | $1.49B | Buy |
1,959,032
+25,931
| +1% | +$19.3M | 0.86% | 13 |
|
|
2025
Q2 | $1.51B | Sell |
1,933,101
-20,348
| -1% | -$15.8M | 0.94% | 14 |
|
|
2025
Q1 | $1.61B | Buy |
1,953,449
+16,319
| +0.8% | +$13.6M | 1.14% | 12 |
|
|
2024
Q4 | $1.5B | Sell |
1,937,130
-16,917
| -0.9% | -$14M | 1.01% | 11 |
|
|
2024
Q3 | $1.73B | Buy |
1,954,047
+12,044
| +0.6% | +$10.8M | 1.2% | 10 |
|
|
2024
Q2 | $1.76B | Sell |
1,942,003
-142,792
| -7% | -$114M | 1.3% | 10 |
|
|
2024
Q1 | $1.62B | Sell |
2,084,795
-18,411
| -0.9% | -$13.1M | 1.11% | 10 |
|
|
2023
Q4 | $1.23B | Sell |
2,103,206
-43,976
| -2% | -$25.7M | 0.91% | 12 |
|
|
2023
Q3 | $1.15B | Sell |
2,147,182
-4,666
| -0.2% | -$2.4M | 0.95% | 11 |
|
|
2023
Q2 | $1.01B | Sell |
2,151,848
-270,762
| -11% | -$114M | 0.79% | 15 |
|
|
2023
Q1 | $832M | Sell |
2,422,610
-22,308
| -0.9% | -$7.52M | 0.62% | 22 |
|
|
2022
Q4 | $894M | Sell |
2,444,918
-29,291
| -1% | -$10.4M | 0.71% | 20 |
|
|
2022
Q3 | $800M | Sell |
2,474,209
-12,064
| -0.5% | -$3.82M | 0.66% | 20 |
|
|
2022
Q2 | $806M | Buy |
2,486,273
+58,178
| +2% | +$17.5M | 0.62% | 23 |
|
|
2022
Q1 | $695M | Sell |
2,428,095
-3,594
| -0.1% | -$925K | 0.46% | 33 |
|
|
2021
Q4 | $672M | Sell |
2,431,689
-106,389
| -4% | -$27M | 0.41% | 52 |
|
|
2021
Q3 | $586M | Sell |
2,538,078
-160,866
| -6% | -$39.7M | 0.37% | 59 |
|
|
2021
Q2 | $619M | Sell |
2,698,944
-278,321
| -9% | -$55.9M | 0.37% | 58 |
|
|
2021
Q1 | $556M | Sell |
2,977,265
-137,724
| -4% | -$26.9M | 0.35% | 58 |
|
|
2020
Q4 | $526M | Sell |
3,114,989
-251,265
| -7% | -$37.5M | 0.34% | 62 |
|
|
2020
Q3 | $498M | Sell |
3,366,254
-200,103
| -6% | -$31M | 0.34% | 59 |
|
|
2020
Q2 | $586M | Sell |
3,566,357
-117,702
| -3% | -$18.1M | 0.41% | 46 |
|
|
2020
Q1 | $511M | Buy |
3,684,059
+165,686
| +5% | +$22.8M | 0.44% | 45 |
|
|
2019
Q4 | $462M | Buy |
3,518,373
+36,789
| +1% | +$4.26M | 0.36% | 59 |
|
|
2019
Q3 | $389M | Sell |
3,481,584
-62,402
| -2% | -$6.95M | 0.34% | 62 |
|
|
2019
Q2 | $393M | Sell |
3,543,986
-273,465
| -7% | -$32.2M | 0.35% | 60 |
|
|
2019
Q1 | $495M | Sell |
3,817,451
-6,742
| -0.2% | -$820K | 0.46% | 46 |
|
|
2018
Q4 | $437M | Buy |
3,824,193
+565,762
| +17% | +$63.2M | 0.47% | 44 |
|
|
2018
Q3 | $350M | Buy |
3,258,431
+41,397
| +1% | +$4.14M | 0.38% | 56 |
|
|
2018
Q2 | $275M | Buy |
3,217,034
+238,504
| +8% | +$19.6M | 0.32% | 69 |
|
|
2018
Q1 | $230M | Buy |
2,978,530
+24,678
| +0.8% | +$1.99M | 0.3% | 73 |
|
|
2017
Q4 | $249M | Buy |
2,953,852
+56,324
| +2% | +$4.79M | 0.32% | 66 |
|
|
2017
Q3 | $248M | Sell |
2,897,528
-7,602
| -0.3% | -$623K | 0.35% | 60 |
|
|
2017
Q2 | $239M | Buy |
2,905,130
+54,878
| +2% | +$4.48M | 0.35% | 58 |
|
|
2017
Q1 | $240M | Buy |
2,850,252
+3,954
| +0.1% | +$317K | 0.37% | 56 |
|
|
2016
Q4 | $209M | Sell |
2,846,298
-44,367
| -2% | -$3.3M | 0.34% | 60 |
|
|
2016
Q3 | $232M | Buy |
2,890,665
+32,919
| +1% | +$2.63M | 0.38% | 54 |
|
|
2016
Q2 | $225M | Sell |
2,857,746
-14,830
| -0.5% | -$1.12M | 0.39% | 54 |
|
|
2016
Q1 | $207M | Buy |
2,872,576
+127,044
| +5% | +$9.61M | 0.36% | 57 |
|
|
2015
Q4 | $237M | Sell |
2,745,532
-32,588
| -1% | -$2.7M | 0.42% | 49 |
|
|
2015
Q3 | $233M | Buy |
2,778,120
+74,081
| +3% | +$6.25M | 0.45% | 47 |
|
|
2015
Q2 | $226M | Sell |
2,704,039
-14,712
| -0.5% | -$1.12M | 0.41% | 52 |
|
|
2015
Q1 | $198M | Buy |
2,718,751
+235,575
| +9% | +$16.8M | 0.36% | 62 |
|
|
2014
Q4 | $173M | Sell |
2,483,176
-49,910
| -2% | -$3.37M | 0.34% | 67 |
|
|
2014
Q3 | $164M | Sell |
2,533,086
-35,536
| -1% | -$2.25M | 0.33% | 68 |
|
|
2014
Q2 | $160M | Sell |
2,568,622
-103,556
| -4% | -$6.18M | 0.33% | 71 |
|
|
2014
Q1 | $157M | Sell |
2,672,178
-39,113
| -1% | -$2.18M | 0.33% | 69 |
|
|
2013
Q4 | $139M | Sell |
2,711,291
-37,762
| -1% | -$1.89M | 0.29% | 78 |
|
|
2013
Q3 | $138M | Sell |
2,749,053
-63,440
| -2% | -$3.32M | 0.3% | 79 |
|
|
2013
Q2 | $138M | Buy |
+2,812,493
| New | +$153M | 0.31% | 71 |
|
Other funds holding LLY
VCM
VPM
Sumitomo Mitsui Trust Group's LLY Position: Q1 2026 in Review
Sumitomo Mitsui Trust Group reduced its Eli Lilly (LLY) stake by 4.3% in Q1 2026, selling an estimated $81.5M and leaving 1,775,707 shares worth $1.63B. The position accounts for 1.06% of the portfolio, ranked #12.
Sumitomo Mitsui Trust Group first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.99B in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Sumitomo Mitsui Trust Group held 1,775,707 shares of Eli Lilly worth $1.63B as of Q1 2026.
- Sumitomo Mitsui Trust Group sold 80,425 Eli Lilly shares in Q1 2026, an estimated $81.5M.
- Eli Lilly made up 1.06% of Sumitomo Mitsui Trust Group's portfolio in Q1 2026, its #12 holding.
- Sumitomo Mitsui Trust Group first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- Sumitomo Mitsui Trust Group's Eli Lilly position peaked at $1.99B in Q4 2025.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Sumitomo Mitsui Trust Group's 13F filing for Q1 2026, filed 30 Apr 2026.